NYSE · Financial Statements

The Cigna Group (CI) Revenue, Earnings & Financial Statements

$299.22 NYSE: CI Market Cap $78.85B

Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

The Cigna Group most recently reported annual revenue of $275.0B, net profit of $6.0B. Revenue grew at an average annual rate of 11.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

The Cigna Group: Revenue rose from $39.8B in 2016 to $275.0B in 2025, a change of +590.2% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 7.8% to 3.3%, a shift of -4.4 percentage points; the most recent year shows net profit of $6.0B.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$39.8B$41.8B$48.6B$153.6B$160.4B$174.1B$180.5B$195.3B$247.1B$275.0B
Operating Expenses$36.8B$37.9B$44.5B$145.5B$152.2B$166.1B$172.1B$186.7B$237.7B$265.8B
Operating Profit$3.1B$3.9B$4.2B$8.1B$8.2B$7.9B$8.4B$8.5B$9.4B$9.1B
Operating Margin7.8%9.4%8.6%5.3%5.1%4.6%4.7%4.4%3.8%3.3%
Other Income−$109.0M−$336.0M−$579.0M−$1.5B$2.7B−$1.2B−$53.0M−$3.0B−$4.1B−$1.5B
Interest$278.0M$252.0M$498.0M$1.7B$1.4B$1.2B$1.2B$1.4B$1.4B$1.4B
Depreciation$610.0M$566.0M$695.0M$3.7B$2.8B$2.9B$2.9B$3.0B$2.8B$2.8B
Profit Before Tax$3.0B$3.6B$3.6B$6.6B$10.9B$6.8B$8.4B$5.5B$5.3B$7.6B
Tax rate (%)38.1%38.1%26.1%22.1%21.9%20.2%19.2%2.6%28.3%17.7%
Net Profit$1.9B$2.2B$2.6B$5.1B$8.5B$5.4B$6.7B$5.2B$3.4B$6.0B
EPS$7.19$9.17$10.54$13.44$22.96$15.75$21.41$17.39$12.12$22.17

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$51.1B$57.3B$60.5B$63.7B$65.6B$65.5B$67.2B$69.7B$72.5B$68.5B$71.7B$73.7B
Operating Expenses$49.1B$55.0B$58.1B$61.1B$63.5B$63.5B$64.8B$67.2B$70.3B$66.1B$69.0B$71.3B
Operating Profit$2.1B$2.3B$2.4B$2.6B$2.2B$2.0B$2.4B$2.6B$2.1B$2.4B$2.7B$2.4B
Operating Margin4.0%3.9%4.0%4.0%3.3%3.0%3.6%3.7%3.0%3.4%3.7%3.3%
Interest$360.0M$322.0M$375.0M$376.0M$362.0M$362.0M$337.0M$347.0M$335.0M$357.0M$356.0M$333.0M
Profit Before Tax$188.0M$79.0M$2.0B$1.2B$2.0B$1.6B$2.0B$2.3B$1.6B$2.3B$2.3B$2.1B
Tax rate (%)-488.8%368.4%18.1%30.8%23.5%14.5%19.3%14.0%24.3%18.0%16.9%19.1%
Net Profit$1.0B−$277.0M$1.5B$739.0M$1.4B$1.3B$1.5B$1.9B$1.2B$1.7B$1.7B$1.4B
EPS$3.49−$0.97$5.45$2.63$5.13$4.85$5.71$6.97$4.64$6.26$6.29$5.47

Over the 10 years reported for The Cigna Group, borrowings increased from $5.0B in 2016 to $31.5B in 2025, cash stood at $7.7B in the latest year, shareholders' equity was $4.0M, current assets covered current liabilities 0.85 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$59.4B$61.8B$153.2B$155.8B$155.5B$154.9B$143.9B$152.8B$155.9B$157.9B
Current Assets$13.4B$9.3B$20.4B$29.8B$27.8B$36.1B$30.1B$37.4B$48.9B$47.8B
Cash$3.2B$3.0B$3.9B$4.6B$10.2B$5.1B$5.9B$7.8B$7.5B$7.7B
Inventory$0$228.0M$2.8B$2.7B$3.2B$3.7B$4.8B$5.6B$6.7B$7.3B
Receivables$3.0B$2.9B$10.2B$10.4B$12.0B$14.6B$17.0B$17.4B$24.1B$28.8B
Fixed Assets$767.0M$756.0M$1.3B$1.8B$1.7B$1.7B$1.3B$877.0M$828.0M$3.7B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$26.1B$28.6B$29.0B$22.4B$24.5B$19.3B$17.1B$18.9B$15.8B$18.5B
Other Assets$6.0B$6.2B$44.5B$44.6B$44.6B$45.8B$45.8B$44.3B$44.4B$44.9B
Total Liabilities$45.6B$48.0B$112.2B$110.4B$105.1B$107.7B$99.0B$106.4B$114.6B$116.0B
Current Liabilities$8.3B$11.0B$31.9B$40.1B$36.0B$43.6B$41.2B$48.7B$58.0B$56.3B
Borrowings$5.0B$5.4B$42.5B$38.0B$33.6B$34.3B$31.6B$30.9B$32.0B$31.5B
Other Liabilities$40.5B$42.5B$69.7B$72.4B$71.5B$73.4B$67.4B$75.5B$82.7B$84.6B
Equity$74.0M$74.0M$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M
Reserves$13.7B$13.7B$41.0B$45.3B$50.3B$47.1B$44.9B$46.2B$41.0B$41.7B

For The Cigna Group, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $8.4B; free cash flow was positive in 10 of 10 years; financing activities used $4.3B in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$4.0B$4.1B$3.8B$9.5B$10.3B$7.2B$8.7B$11.8B$10.4B$9.6B
Investing Cash Flow−$3.0B−$2.2B−$26.9B−$1.8B$1.9B−$4.8B$1.8B−$6.7B−$3.5B−$5.6B
Financing Cash Flow−$113.0M−$3.2B−$765.0M−$2.2B−$4.4B−$7.9B−$7.7B−$2.8B−$7.4B−$4.3B
Net Cash Flow$1.2B−$213.0M$883.0M$1.6B$4.8B−$4.7B$428.0M$2.4B$594.0M$126.0M
Free Cash Flow$3.6B$3.6B$3.2B$8.4B$9.3B$6.0B$7.4B$10.2B$9.0B$8.4B

Valuation & Return Ratios

MetricValue
PEG Ratio-42.58
EV / EBITDA8.24
FCF Yield10.56%
Quick Ratio0.74
Interest Coverage6.94
Return 1Y12.12%
Return 3Y8.52%
Return 5Y49.70%

The Cigna Group (CI) financials — frequently asked questions

What is The Cigna Group's annual revenue?

The Cigna Group (CI) reported annual revenue of $275.0B in its most recent fiscal year.

What is The Cigna Group's net profit?

The Cigna Group (CI) reported net profit of $6.0B in its most recent fiscal year.

What is CI EV/EBITDA?

The Cigna Group's enterprise value to EBITDA (EV/EBITDA) ratio is 8.24.

Revenue and earnings of other Medical - Healthcare Plans stocks

UNH revenue $447.6BCVS revenue $402.1BELV revenue $199.1BHUM revenue $129.7BCNC revenue $194.8BMOH revenue $45.4BOSCR revenue $11.7BPGNY revenue $1.3BCLOV revenue $1.9BALHC revenue $3.9BAll Medical - Healthcare Plans stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
CI Overview CI Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.